Post-mortem analyses of AD patient brains report increased levels of activated Akt in mid-temporal and mid-frontal cortex soluble fractions (Rickle et al., 2004) as well as increased phosphorylation of Akt and of Akt substrates in membrane-bound fractions (Griffin et al., 2005). The gene discussed is AKT1; the disease is Alzheimer disease.